Peio Errarte
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 15
- Peptidase Inhibition and Analysis 12
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Gorka LarrinagaJosé I. LópezMaider BeitiaJ.C. AnguloRafael PulidoCarmen EtxezarragaItxaro PérezLorena Blanco
- Journals
- Cancers (5 papers)International Journal of Medical Sciences (3 papers)PLoS ONE (3 papers)Human Pathology (2 papers)Scientific Reports (1 paper)
- Partner nations
- SpainNorwayUnited Kingdom
In The Last Decade
Peio Errarte
21 papers receiving 470 citations
Peers
Comparison fields: 5 of 59
- Oncology 289
- Cancer Research 127
- Pulmonary and Respiratory Medicine 147
- Endocrinology, Diabetes and Metabolism 43
- Molecular Biology 173
Countries citing papers authored by Peio Errarte
This map shows the geographic impact of Peio Errarte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peio Errarte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peio Errarte more than expected).
Fields of papers citing papers by Peio Errarte
This network shows the impact of papers produced by Peio Errarte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peio Errarte. The network helps show where Peio Errarte may publish in the future.
Co-authors
The 25 scholars most cited alongside Peio Errarte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 7 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 34 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 26 | |
| 8 | 2020 | 31 | |
| 9 | 2019 | 11 | |
| 10 | 2019 | 10 | |
| 11 | 2019 | 52 | |
| 12 | 2019 | 50 | |
| 13 | 2017 | 33 | |
| 14 | 2016 | 50 | |
| 15 | 2016 | 50 | |
| 16 | 2015 | 5 | |
| 17 | 2015 | 30 | |
| 18 | 2014 | 22 | |
| 19 | 2013 | 11 | |
| 20 | 2013 | 10 |
About Peio Errarte
Peio Errarte is a scholar working on Oncology, Cancer Research, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Genetics, having authored 21 papers that have together received 470 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (12 papers), Renal cell carcinoma treatment (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Bladder and Urothelial Cancer Treatments (4 papers), Renin-Angiotensin System Studies (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Hormonal Regulation and Hypertension (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Oncology (289 citations), Cancer Research (127 citations), Pulmonary and Respiratory Medicine (147 citations), Endocrinology, Diabetes and Metabolism (43 citations) and Molecular Biology (173 citations). Peio Errarte has collaborated with scholars based in Spain, Norway and United Kingdom. Frequent co-authors include Gorka Larrinaga, José I. López, Maider Beitia, J.C. Angulo, Rafael Pulido, Carmen Etxezarraga, Itxaro Pérez, Lorena Blanco, Begoña Sanz and Caroline E. Nunes‐Xavier. Their work appears in journals such as Cancers, International Journal of Medical Sciences, PLoS ONE, Human Pathology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.